FPWM
IBB icon

FSB Premier Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

FSB Premier Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-150
Closed -$22K – 327
2021
Q4 		$22K Buy
+150
New +$23.2K 0.01% 333

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FSB Premier Wealth Management's IBB Position: Q1 2022 in Review

FSB Premier Wealth Management sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 150 shares — an estimated $22K sold.

FSB Premier Wealth Management first reported a position in IBB in Q4 2021 and held it in 1 quarter. The position peaked at $22K in Q4 2021. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

  • FSB Premier Wealth Management reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
  • FSB Premier Wealth Management sold 150 iShares Biotechnology ETF shares in Q1 2022, an estimated $22K.
  • FSB Premier Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2021 and held it in 1 quarter.
  • FSB Premier Wealth Management's iShares Biotechnology ETF position peaked at $22K in Q4 2021.
  • 897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on FSB Premier Wealth Management's 13F filing for Q1 2022, filed 14 Apr 2022.